ABOUT PROCYL THERAPEUTICS Pvt Ltd
We Care, We Cure
At Procyl, we are driven by this simple mission. Our team is committed to advancing healthcare by creating therapies that are both effective and affordable.
Who We Are
Innovating for Life
Founded in 2024 by a team of scientists and industry professionals, Procyl Therapeutics is on a mission to discover and develop innovative treatments for cancer and other life-threatening diseases.
What We Do
Precision Treatment, Profound Impact
We envision improving the lives of patients in India and beyond. By transforming cutting-edge academic research into real-world treatments, we aim to create accessible healthcare solutions for all.
Our Expertise
Transforming Healthcare
With a strong focus on drug discovery, microbiology, bio-analytics, and small molecule synthesis, we aim to shape the future of healthcare.
What Drives Us
Local Innovations, Global Solutions
Our mission aligns with the “Make in India” initiative, contributing to local innovation and strengthening India’s role in the global pharmaceutical industry.
Our Goals
Collaboration for a Cure
Through sustainable partnerships with academic institutions, research organizations, and industry players, Procyl will tackle the challenges of drug discovery for curing cancer and other deadly diseases.
Our Leadership Team
Procyl Therapeutics is built on years of research, resulting in 14 Indian and one US patent. The founders, Dr. Sivapriya Kirubakaran, Dr. Vijay Thiruvenkatam, Dharmeshkumar Patel, and Ripal Khamar, are passionate about using these IPRs to develop therapies that are modern, safe, high-quality, and robust.
English (UK) 
English (United States)